pembrolizumab
merck
['pembro', 'rcc,(-irccs),(-srcc),(-urcc)']
#asco22 poster discussion session: agree enjoyed the brilliant discussion by issues to be considered in the context of subsequent rx of mrcc after adjuvant pembrolizumab. great discussion with 
Medical Oncologist. Editor-in-chief: @ASCO Daily News; Presidential Endowed Chair, @HuntsmanCancer (NCI-CCC) @UUtah, FCOI https://t.co/qcdl195o3E